Limits...
A descriptive study of clinical, hematological, and biochemical parameters of inhalant users seeking treatment at a tertiary care center in India.

Quraishi R, Pattanayak RD, Jain R, Dhawan A - Indian J Psychol Med (2013)

Bottom Line: There was no evidence of leucopenia.The study adds to the limited date available on the treatment-seeking inhalant users from Indian settings.There is a need to examine the pattern of inhalant use in larger samples, across multiple sites in a prospective manner.

View Article: PubMed Central - PubMed

Affiliation: Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.

ABSTRACT

Background: Inhalant (or solvent) abuse is the purposeful inhalation of vapors or gases, intended to produce pleasurable psychoactive effects. There is a dearth of Indian studies on inhalant users.

Aim: The present study aimed to describe the socio-demographic, clinical, and psychosocial characteristics of inhalant users visiting a Tertiary Care Center in North India.

Materials and methods: The study was a retrospective chart review for 50 inhalant users who sought treatment for the first time from the center over a period of 2 years. All patients seeking treatment for inhalant use at the center were evaluated by a psychiatrist.

Results: Mean age of the sample was 17.16±4.09 years and majority comprised of children and adolescents (72.2%). There were only three girls (6%). Majority comprised of school drop-outs (82%), from lower socio-economic status (80%). Mean age of initiation of first substance was 14.13±4.27 years and inhalants were first drugs for 38%. Duration of inhalant use ranged between 1 month and 7.5 years. Use was mostly uninterrupted, and 88% were dependent users. Correction fluid was the commonest product, used by huffing or sniffing. A large majority (86%) had used at least one other substance besides inhalants, and 8% reported involvement in high-risk sexual behaviors. Comorbid psychiatric disorder was seen in 8% of sample. Positive family history was observed in 30% of the sample. The mean hemoglobin of the sample was 11.88±0.60, with low hemoglobin in 25% of users. Neutrophils, lymphocytes, eosinophils, and monocytes were elevated beyond normal in 10.8%, 6.5%, 15.2%, and 7.5%, respectively. There was no evidence of leucopenia. Bilirubin and serum glutamic pyruvic transaminase was elevated in 6.6% and 13% of inhalant users, respectively.

Conclusion: The study adds to the limited date available on the treatment-seeking inhalant users from Indian settings. There is a need to examine the pattern of inhalant use in larger samples, across multiple sites in a prospective manner.

No MeSH data available.


Related in: MedlinePlus

Life-time and current substance use in the sample (n = 50)
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3775050&req=5

Figure 2: Life-time and current substance use in the sample (n = 50)

Mentions: Figure 2 shows the life-time and current (past 1 month) substance use in the sample. Table 3 shows the substance use and psychiatric comorbidities in the sample of inhalant users. A large majority (86%) of the sample has used at least one other substance besides inhalants. Besides inhalants, tobacco, alcohol, and cannabis were the three commonly used drugs in that order. Comorbid psychiatric disorder was seen in 8% of the sample.


A descriptive study of clinical, hematological, and biochemical parameters of inhalant users seeking treatment at a tertiary care center in India.

Quraishi R, Pattanayak RD, Jain R, Dhawan A - Indian J Psychol Med (2013)

Life-time and current substance use in the sample (n = 50)
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3775050&req=5

Figure 2: Life-time and current substance use in the sample (n = 50)
Mentions: Figure 2 shows the life-time and current (past 1 month) substance use in the sample. Table 3 shows the substance use and psychiatric comorbidities in the sample of inhalant users. A large majority (86%) of the sample has used at least one other substance besides inhalants. Besides inhalants, tobacco, alcohol, and cannabis were the three commonly used drugs in that order. Comorbid psychiatric disorder was seen in 8% of the sample.

Bottom Line: There was no evidence of leucopenia.The study adds to the limited date available on the treatment-seeking inhalant users from Indian settings.There is a need to examine the pattern of inhalant use in larger samples, across multiple sites in a prospective manner.

View Article: PubMed Central - PubMed

Affiliation: Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.

ABSTRACT

Background: Inhalant (or solvent) abuse is the purposeful inhalation of vapors or gases, intended to produce pleasurable psychoactive effects. There is a dearth of Indian studies on inhalant users.

Aim: The present study aimed to describe the socio-demographic, clinical, and psychosocial characteristics of inhalant users visiting a Tertiary Care Center in North India.

Materials and methods: The study was a retrospective chart review for 50 inhalant users who sought treatment for the first time from the center over a period of 2 years. All patients seeking treatment for inhalant use at the center were evaluated by a psychiatrist.

Results: Mean age of the sample was 17.16±4.09 years and majority comprised of children and adolescents (72.2%). There were only three girls (6%). Majority comprised of school drop-outs (82%), from lower socio-economic status (80%). Mean age of initiation of first substance was 14.13±4.27 years and inhalants were first drugs for 38%. Duration of inhalant use ranged between 1 month and 7.5 years. Use was mostly uninterrupted, and 88% were dependent users. Correction fluid was the commonest product, used by huffing or sniffing. A large majority (86%) had used at least one other substance besides inhalants, and 8% reported involvement in high-risk sexual behaviors. Comorbid psychiatric disorder was seen in 8% of sample. Positive family history was observed in 30% of the sample. The mean hemoglobin of the sample was 11.88±0.60, with low hemoglobin in 25% of users. Neutrophils, lymphocytes, eosinophils, and monocytes were elevated beyond normal in 10.8%, 6.5%, 15.2%, and 7.5%, respectively. There was no evidence of leucopenia. Bilirubin and serum glutamic pyruvic transaminase was elevated in 6.6% and 13% of inhalant users, respectively.

Conclusion: The study adds to the limited date available on the treatment-seeking inhalant users from Indian settings. There is a need to examine the pattern of inhalant use in larger samples, across multiple sites in a prospective manner.

No MeSH data available.


Related in: MedlinePlus